 |
|
Consequences of Verteporfin Photodynamic Therapy on Choroidal Neovascular Membranes
Olcay Tatar, MD;
Edwin Kaiserling, MD;
Annemarie Adam;
Faik Gelisken, MD;
Kei Shinoda, MD, PhD;
Michael Völker, MD;
Bart A. Lafaut, MD;
Karl Ulrich Bartz-Schmidt, MD;
Salvatore Grisanti, MD
Arch Ophthalmol. 2006;124:815-823.
Objective To examine the impact of photodynamic therapy (PDT) on angiogenesis in human choroidal neovascular membranes with respect to vascular endothelial growth factor (VEGF) expression, proliferation, and vascularization.
Methods Retrospective review of an interventional case series of 50 patients (50 eyes) who underwent removal of choroidal neovascular membranes. Choroidal neovascularization was secondary to age-related macular degeneration. Twenty patients were treated with PDT 3 to 655 days before surgery. Choroidal neovascular membranes were stained for CD34, CD105, Ki-67, cytokeratin 18, and VEGF. Thirty choroidal neovascular membranes secondary to age-related macular degeneration without previous treatment were used as controls.
Results Specimens without pretreatment disclosed varying degrees of vascularization, proliferative activity, and VEGF expression by different cells. Specimens treated with PDT 3 days earlier showed mostly occluded vessels, damaged endothelial cells, and low proliferative activity. In contrast, specimens excised at later time points after PDT were highly vascularized and proliferating. This chronology was associated with an impressive VEGF immunoreactivity unique to retinal pigment epithelial cells shortly after PDT that also shifted to other cells at later time points.
Conclusions Photodynamic therapy induces selective vascular damage in choroidal neovascular membranes. The effectiveness and selectivity of this treatment, however, seem to be jeopardized by a rebound effect initiated by enhanced VEGF expression in retinal pigment epithelial cells.
Author Affiliations: University Eye Clinic at the Centre for Ophthalmology, Eberhard-Karls-University (Drs Tatar, Gelisken, Völker, Bartz-Schmidt, and Grisanti) and Department of Pathology, University of Tübingen (Dr Kaiserling and Ms Adam), Tübingen, Germany; Laboratory of Visual Physiology, National Institute of Sensory Organs, Tokyo, Japan (Dr Shinoda); and Department of Ophthalmology, AZ StJan, Bruges, Belgium (Dr Lafaut).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Early Effects of Intravitreal Triamcinolone Acetonide on Inflammation and Proliferation in Human Choroidal Neovascularization
Tatar et al.
Arch Ophthalmol 2009;127:275-281.
ABSTRACT
| FULL TEXT
Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation
Tatar et al.
Br J Ophthalmol 2009;93:159-165.
ABSTRACT
| FULL TEXT
Effect of Bevacizumab on Inflammation and Proliferation in Human Choroidal Neovascularization
Tatar et al.
Arch Ophthalmol 2008;126:782-790.
ABSTRACT
| FULL TEXT
Early Effects of Triamcinolone on Vascular Endothelial Growth Factor and Endostatin in Human Choroidal Neovascularization
Tatar et al.
Arch Ophthalmol 2008;126:193-199.
ABSTRACT
| FULL TEXT
Histopathological findings in postmortem eyes after photodynamic therapy for choroidal neovascularisation in age-related macular degeneration: report of two cases
Kang et al.
Br J Ophthalmol 2007;91:1602-1606.
ABSTRACT
| FULL TEXT
Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy
Tatar et al.
Br J Ophthalmol 2007;91:1183-1189.
ABSTRACT
| FULL TEXT
Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes
Tatar et al.
Br J Ophthalmol 2007;91:166-173.
ABSTRACT
| FULL TEXT
From the Library
Br J Ophthalmol 2006;90:1214-1214.
FULL TEXT
|
